Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

BELLUS Health, Inc. (BLU.TO)

-Toronto
1.06 Down 0.04(3.64%) Aug 28, 3:10PM EDT
Add to Portfolio
Prev Close:1.10
Open:1.10
Bid:1.07
Ask:1.12
1y Target Est:N/A
Beta:3.73324
Earnings Date:Nov 3 - Nov 9 (Est.)
Day's Range:1.06 - 1.10
52wk Range:0.76 - 1.80
Volume:9,200
Avg Vol (3m):30,098
Market Cap:50.27M
P/E (ttm):N/A
EPS (ttm):-0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.03
Quarterly EPS Est (Mar-15) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BELLUS Health Inc., together with its subsidiaries, focuses on the research and development of pharmaceutical drug candidates. The company’s lead program is KIACTA, which is in Phase III clinical trial for the treatment of AA amyloidosis. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback